ClinicalTrials.govpublic full text
Efficacy and Safety of Rifaximin-α in Treating MASLD
metabolic dysfunction-associated steatotic liver disease
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 152453
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.